Objectives: A retrospective study of 284 cardiovascular surgical patients seen between January 1, 1999 and September 30, 2004 was conducted to determine whether appropriate antimicrobial prophylaxis reduces surgical site infection (SSI) rate.
Methods: The study period was divided into four according to the period of antimicrobial prophylaxis administration and the SSI rate was evaluated. The first period from January 1 to August 31, 1999 served as an 8-month baseline period, during which the mean duration of antimicrobial prophylaxis was 8 days (Group A; 36 patients). The 10-month period from September 1, 1999 to November 30, 2000 was the next period (Group B; 64 patients). The Centers for Disease Control and Prevention (CDC) guidelines for preventing SSI were introduced during this period. The mean duration of antimicrobial prophylaxis was reduced to 4 days. The 16-month period from December 1, 2000, to March 31, 2002 was the third period (Group C; 59 patients). The mean duration of antimicrobial prophylaxis was reduced to 24 hours. The fourth period lasted 30 months from April 1, 2002, to September 30, 2004 (Group D; 125 patients). From the beginning of this period, the administration of antimicrobial prophylaxis was limited to only during surgery.
Results: The rate of SSI was 8.3% (superficial SSI : 2.8%, deep SSI (mediastinitis) : 5.6%) in Group A, 1.6% (0%, 1.6%) in Group B, 0% (0%, 0%) in Group C, and 0.8% (0%, 0.8%) in Group D. The rate of SSI was significantly lower in Group D than in Group A (
P = 0.035) despite the reduction in antibiotics.
Conclusions: Careful management and appropriate antimicrobial prophylaxis according to the CDC recommendations have a beneficial effect on reducing SSI in cardiovascular surgery.
View full abstract